Skip to main content

Peer Review reports

From: Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab

Original Submission
20 Apr 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
24 Jun 2016 Editorially accepted
12 Jul 2016 Article published 10.1186/s12883-016-0625-0

You can find further information about peer review here.

Back to article page